These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10893462)

  • 1. Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol.
    Romano PE; Phillips PJ
    Binocul Vis Strabismus Q; 2000; 15(2):187-96. PubMed ID: 10893462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001).
    Romano PE; Robinson JA
    Binocul Vis Strabismus Q; 2000; 15(2):175-86. PubMed ID: 10893461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient management of traumatic hyphemas in children.
    Coats DK; Viestenz A; Paysse EA; Plager DA
    Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traumatic hyphema: outcomes of outpatient management.
    Shiuey Y; Lucarelli MJ
    Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid in the treatment of pediatric traumatic hyphema.
    Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
    Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of risk for secondary hemorrhage in traumatic hyphema.
    Rahmani B; Jahadi HR; Rajaeefard A
    Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
    Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
    Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposition to treatment of traumatic hyphema with antifibrinolytics/steroids.
    Romano PE; Smith RJ
    Binocul Vis Strabismus Q; 2000; 15(2):163-5. PubMed ID: 10893458
    [No Abstract]   [Full Text] [Related]  

  • 10. The incidence of rebleeding in traumatic hyphema.
    Witteman GJ; Brubaker SJ; Johnson M; Marks RG
    Ann Ophthalmol; 1985 Sep; 17(9):525-6, 528-9. PubMed ID: 4062157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is topical corticosteroid necessary in traumatic hyphema?
    Türkoğlu EB; Celik T; Celik E; Ozkan N; Bursalı O; Coşkun SB; Alagoz G
    J Fr Ophtalmol; 2014 Oct; 37(8):613-7. PubMed ID: 25199483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traumatic hyphema management: assuring compliance with outpatient care; steroidophobia: rational or irrational?
    Romano PE
    Binocul Vis Strabismus Q; 2000; 15(2):166-8. PubMed ID: 10893459
    [No Abstract]   [Full Text] [Related]  

  • 14. Traumatic hyphema and patient outcomes--an oversight.
    Shiuey Y; Lucarelli MJ
    Ophthalmology; 1998 Dec; 105(12):2165. PubMed ID: 9855140
    [No Abstract]   [Full Text] [Related]  

  • 15. The detrimental effect of aspirin on hyphema rebleed.
    Gorn RA
    Ann Ophthalmol; 1979 Mar; 11(3):351-5. PubMed ID: 453740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapy in anosmia: relevance of steroid-responsiveness.
    Stenner M; Vent J; Hüttenbrink KB; Hummel T; Damm M
    Laryngoscope; 2008 Sep; 118(9):1681-6. PubMed ID: 18677278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and secondary bleeding after traumatic hyphema.
    Marcus M; Biedner B; Lifshitz T; Yassur Y
    Ann Ophthalmol; 1988 Apr; 20(4):157-8. PubMed ID: 3288070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Traumatic hyphema caused by eye injuries].
    Luksza L; Homziuk M; Nowakowska-Klimek M; Glasner L; Iwaszkiewicz-Bilikiewicz B
    Klin Oczna; 2005; 107(4-6):250-1. PubMed ID: 16118929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
    Beiran I; Talmon T; Miller B
    Isr Med Assoc J; 2002 Nov; 4(11):1009-10. PubMed ID: 12489492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
    Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
    Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.